A detailed history of Bank Of America Corp transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Bank Of America Corp holds 275,265 shares of AVXL stock, worth $3.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
275,265
Previous 600,359 54.15%
Holding current value
$3.08 Million
Previous $2.53 Million 38.29%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.11 - $7.04 $1.34 Million - $2.29 Million
-325,094 Reduced 54.15%
275,265 $1.56 Million
Q2 2024

Aug 14, 2024

SELL
$3.39 - $5.02 $850,106 - $1.26 Million
-250,769 Reduced 29.46%
600,359 $2.53 Million
Q1 2024

May 15, 2024

BUY
$4.55 - $6.75 $2.94 Million - $4.36 Million
646,190 Added 315.31%
851,128 $4.33 Million
Q4 2023

Feb 14, 2024

SELL
$5.04 - $9.95 $270,280 - $533,588
-53,627 Reduced 20.74%
204,938 $1.91 Million
Q2 2023

Aug 14, 2023

SELL
$7.66 - $9.5 $4.43 Million - $5.49 Million
-578,210 Reduced 69.1%
258,565 $2.1 Million
Q1 2023

May 12, 2023

BUY
$8.32 - $11.75 $2.75 Million - $3.88 Million
330,321 Added 65.22%
836,775 $7.17 Million
Q4 2022

Feb 10, 2023

BUY
$7.65 - $14.43 $1.95 Million - $3.68 Million
254,742 Added 101.2%
506,454 $4.69 Million
Q3 2022

Nov 14, 2022

BUY
$8.9 - $12.86 $1.24 Million - $1.78 Million
138,780 Added 122.89%
251,712 $2.6 Million
Q2 2022

Aug 12, 2022

SELL
$7.31 - $12.84 $1.17 Million - $2.06 Million
-160,291 Reduced 58.67%
112,932 $1.13 Million
Q1 2022

May 16, 2022

BUY
$9.74 - $17.69 $1.22 Million - $2.21 Million
124,953 Added 84.27%
273,223 $3.36 Million
Q4 2021

Feb 08, 2022

BUY
$16.88 - $23.31 $1.97 Million - $2.72 Million
116,703 Added 369.7%
148,270 $2.57 Million
Q3 2021

Nov 15, 2021

SELL
$16.82 - $25.75 $2 Million - $3.06 Million
-118,875 Reduced 79.02%
31,567 $567,000
Q2 2021

Sep 13, 2021

BUY
$10.16 - $28.86 $1.53 Million - $4.34 Million
150,442 New
150,442 $3.44 Million

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $871M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.